JoomFish-Language Selection
|
The Pulmonary-Allergy Drugs Advisory Committee is meeting today to review InterMune's NDA for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis. As a result, trading of the company's stock has been halted. InterMune release |
Adebiotech
ALMA
Alsace Biovalley
Amanda Conrad Translations
Actulabo
Hungarian Biotechnology Association
Px therapeutics
Vivactis Advance
Commission Européenne
Agence Nationale de la recherche
HAS
Inserm
Ministère de l'enseignement supérieur et de la recherche
Angels santé
Cerenis therapeutics
CISS
Fovea pharmaceuticals
IMS Health
Janssen Cilag
Paris Biotech Santé
Pharmaceutiques
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Europharm
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Oxo pharma
Px therapeutics
Px therapeutics
Px therapeutics
RWS GROUP
Px therapeutics
Sigma
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Advanstar
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
PMGROUP
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
STP Pharma
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
